The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,329,977 in first-year total cost, median $1,664,989.
Most frequent study sections
- Special Emphasis Panel[ZAI1 DR-A (J1)]2
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | A Pilot Clinical Trial for HIV-1 Eradication1U01AI117841-01 | KURITZKES, DANIEL R.LICHTERFELD, MATHIAS | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,908,495 | ZAI1 |
| 2015 | A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection1U01AI117844-01 | MARGOLIS, DAVID M. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,421,482 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.